In this study, we demonstrated, for the first time in a cohort of Brazilian adults, a prevalence of 6.7% of IFN-α2 and/or IFN-ω neutralizing auto-Abs (10 ng/mL) in critically ill individuals hospitalized with COVID-19. This evidence concerns the gene IFNA2 and COVID-19.